Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies — Stella

Recruiting

Back to Cancer trials

Trial locations(8 sites)

United States

Mercy Hospital - FTS, Fort Smith, Arkansas

Frederick Health Hospital, Frederick, Maryland

Mercy Hospital - SPG, Springfield, Missouri

Mercy Hospital - South, St Louis, Missouri

Mercy Hospital -STL, St Louis, Missouri

Key details

Sponsor

Elephas

Enrollment target

~2,000 participants

Started

April 2025

Primary completion

April 2035

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov